Home > Journals > Minerva Urology and Nephrology > Past Issues > Minerva Urology and Nephrology 2022 October;74(5) > Minerva Urology and Nephrology 2022 October;74(5):499-501

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

MINERVA OPINION EDITORIAL   Free accessfree

Minerva Urology and Nephrology 2022 October;74(5):499-501

DOI: 10.23736/S2724-6051.22.04861-3

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Can Rezum stand out as the most versatile and better performing minimally invasive treatment for the management of LUTS related to BPH?

Giampaolo SIENA 1, Riccardo TELLINI 1, 2 , Luca CINDOLO 3

1 Unit of Urological Oncologic Minimally-Invasive Robotic Surgery and Andrology, Careggi Hospital, University of Florence, Florence, Italy; 2 Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 3 Department of Urology, Villa Stuart Private Hospital, Rome, Italy



top of page